Literature DB >> 31068312

[Research progress of exosomes in epithelial-mesenchymal transition].

Jingyu Quan1, Zibin Lu1, Linzhong Yu1, Chunlin Fan2, Huihui Cao1, Junshan Liu1.   

Abstract

Exosome, a membranous vesicle with biological activity, not only transmits active substances between cells but also transfers information between cells to participate in cell communication. Epithelial-mesenchymal transition (EMT) is a process by which epithelial cells acquire migratory and invasive properties to become mesenchymal stem cells. EMT is essential for the development of a spectrum of diseases. Studies have shown that exosomes have dual effects on EMT to, on the one hand, promote EMT and tumor cell invasion and metastasis and accelerate angiogenesis and tumor growth; on the other hand, exosomes can suppress tumor cell invasion, inhibit fibrosis of the heart, liver and kidney, and improve myocardial infarction by inhibiting EMT. Exosomes modulate EMT-related signaling pathways by carrying EMT-related proteins or miRNA to exert their bi-directional regulatory effects.

Entities:  

Keywords:  epithelial-mesenchymal transition; exosomes; fibrosis; tumor

Mesh:

Substances:

Year:  2019        PMID: 31068312      PMCID: PMC6765673          DOI: 10.12122/j.issn.1673-4254.2019.03.19

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  40 in total

Review 1.  Exosomes--vesicular carriers for intercellular communication.

Authors:  Mikael Simons; Graça Raposo
Journal:  Curr Opin Cell Biol       Date:  2009-05-11       Impact factor: 8.382

2.  MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells.

Authors:  Haibo Hu; Zhenlei Xu; Chang Li; Chun Xu; Zhe Lei; Hong-Tao Zhang; Jun Zhao
Journal:  Lung Cancer       Date:  2016-04-27       Impact factor: 5.705

Review 3.  Targeting EMT in cancer: opportunities for pharmacological intervention.

Authors:  Felicity M Davis; Teneale A Stewart; Erik W Thompson; Gregory R Monteith
Journal:  Trends Pharmacol Sci       Date:  2014-07-16       Impact factor: 14.819

4.  Production and characterization of clinical grade exosomes derived from dendritic cells.

Authors:  Henry G Lamparski; Anita Metha-Damani; Jenq-Yuan Yao; Sanjay Patel; Di-Hwei Hsu; Curtis Ruegg; Jean-Bernard Le Pecq
Journal:  J Immunol Methods       Date:  2002-12-15       Impact factor: 2.303

5.  Loss of exosomal miR-148b from cancer-associated fibroblasts promotes endometrial cancer cell invasion and cancer metastasis.

Authors:  Bi-Lan Li; Wen Lu; Jun-Jie Qu; Lei Ye; Gui-Qiang Du; Xiao-Ping Wan
Journal:  J Cell Physiol       Date:  2018-08-26       Impact factor: 6.384

Review 6.  The emerging role of exosomes in epithelial-mesenchymal-transition in cancer.

Authors:  Laura Jayne Vella
Journal:  Front Oncol       Date:  2014-12-19       Impact factor: 6.244

Review 7.  EMT in Breast Carcinoma-A Review.

Authors:  Joema Felipe Lima; Sharon Nofech-Mozes; Jane Bayani; John M S Bartlett
Journal:  J Clin Med       Date:  2016-07-14       Impact factor: 4.241

Review 8.  Deciphering Epithelial-Mesenchymal Transition Regulatory Networks in Cancer through Computational Approaches.

Authors:  Gerhard A Burger; Erik H J Danen; Joost B Beltman
Journal:  Front Oncol       Date:  2017-08-03       Impact factor: 6.244

9.  Bone Marrow-Derived Mesenchymal Stem Cells-Derived Exosomes Promote Survival of Retinal Ganglion Cells Through miRNA-Dependent Mechanisms.

Authors:  Ben Mead; Stanislav Tomarev
Journal:  Stem Cells Transl Med       Date:  2017-01-26       Impact factor: 6.940

10.  HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway.

Authors:  Lu Chen; Piao Guo; Yuchao He; Ziye Chen; Liwei Chen; Yi Luo; Lisha Qi; Yuanyuan Liu; Qiang Wu; Yunlong Cui; Feng Fang; Xiaofang Zhang; Tianqiang Song; Hua Guo
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.